Payer perceptions of the use of real-world evidence in oncology-based decision making

BACKGROUND: Randomized controlled trials (RCTs), the gold standard of safety and efficacy evidence, are conducted in select patients that may not mirror real-world populations. As a result, healthcare decision makers may have limited information when making formulary decisions, especially in oncolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Brixner, Diana, Biskupiak, Joseph, Oderda, Gary, Burgoyne, Douglas, Malone, Daniel C, Arondekar, Bhakti, Niyazov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390932/
https://www.ncbi.nlm.nih.gov/pubmed/34337998
http://dx.doi.org/10.18553/jmcp.2021.27.8.1096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390932/
https://www.ncbi.nlm.nih.gov/pubmed/34337998
http://dx.doi.org/10.18553/jmcp.2021.27.8.1096

Ejemplares similares